Avastin to Remain Leader in the Colorectal Cancer Drugs
Roche’s anti-angiogenesis drug Avastin (bevacizumab) has held a dominant position in the CRC market for many years...
Stay updated with breaking news from Trial Status. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Roche’s anti-angiogenesis drug Avastin (bevacizumab) has held a dominant position in the CRC market for many years...
LONDON, July 14, 2022 (GLOBE NEWSWIRE) -- The "Colorectal Cancer – Global Drug Forecast and Market Analysis to 2028" market research report offered by
New York, June 24, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Ventilator Associated Pneumonia (VAP) Clinical Trial
Summary clinical trial report, “Osteoporosis Clinical Trial Anaylsis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top...
As of April 2022, 112 social anxiety disorder clinical trials were conducted in North America ...